UCB extends label for Cimzia to cover rare autoimmune condition - The Pharma Letter

UCB extends label for Cimzia to cover rare autoimmune condition  The Pharma Letter

Belgium's UCB has won an expansion to the label for Cimzia (certolizumab pegol) in the USA, to include certain adults with active non-radiographic axial ...